v3.22.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 66,837 $ 55,900
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Amortization And Non-Cash Lease Expense 30,577 30,459
Accounts Receivable, Credit Loss Expense (Reversal) (3,377) (7,849)
Gain (Loss) on Disposition of Assets (1,598) (131)
Deferred income taxes 2,746 4,577
Share-based Payment Arrangement, Noncash Expense 5,503 4,874
Changes in operating assets and liabilities:    
Increase (Decrease) in Accounts Receivable 81,220 117,818
Increase (Decrease) in Inventories (71,108) 25,117
Increase (Decrease) in Prepaid Expense and Other Assets (17,604) (11,150)
Increase (Decrease) in Prepaid Expense and Other Assets 17,604 11,150
Increase (Decrease) in Other Noncurrent Assets 1,443 (51)
Increase (Decrease) in Accounts Payable (20,823) (41,194)
Increase (Decrease) in Accrued Liabilities (81,371) (27,253)
Increase (Decrease) in Income Taxes Payable (11,004) (19,291)
Increase (Decrease) in Other Operating Assets and Liabilities, Net 15,979 21,273
Increase (Decrease) in Other Noncurrent Liabilities 440 (18)
Net cash provided by operating activities (33,788) 110,899
Cash flows from investing activities:    
Payments to Acquire Short-term Investments (44,877) 0
Proceeds from Sale, Maturity and Collection of Short-term Investments 984 1,054
Payments to Acquire Productive Assets 12,885 3,896
Net cash used in investing activities (56,778) (2,842)
Cash flows from financing activities:    
Proceeds from Lines of Credit 0 7,753
Repayments of Lines of Credit 0 (7,532)
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 2,512 13,772
Payment, Tax Withholding, Share-based Payment Arrangement (3,959) (5,358)
Payments for Repurchase of Common Stock (217,317) (11,223)
Payments of Dividends 19,151 17,285
Net cash used in financing activities (237,915) (19,873)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 317 (5,268)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total (328,164) 82,916
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 435,240 873,641
Supplemental disclosures of cash flow information:    
Income Taxes Paid 18,205 37,534
Supplemental disclosures of non-cash investing activities:    
Capital expenditures incurred but not yet paid $ 6,702 $ 2,832

Source